Additionally, patients with SCLC were also categorized into high-risk and low-risk groups based on RNA expression levels of four genes (HLA class II, CD274 encoding PD-L1, FOXP3, CD4). The gene discussed is FOXP3; the disease is small cell lung carcinoma.